Cathay International Holdings Ltd. announced that Lansen Pharmaceutical Holdings Ltd, the company's 50.56% owned subsidiary, has announced that Mr. Liu Bangmin has resigned as an executive director of Lansen, a member of the executive committee and the chief executive officer of the Lansen group with effect on 31 January 2018 due to his decision to devote more time to his family. Mr. Liu has confirmed that he has no disagreement with the board of Lansen and there is no matter that needs to be brought to the attention of the shareholders of Lansen in relation to his resignation.